SUMMARY The purpose of the present study was to compare the effects of N-dimethyl propranolol (DMP), the quaternary derivative of propranolol, and propranolol on the transmural distribution (endo/epi) of coronary blood flow in normal and ischemic regions of the myocardium. The distribution of blood flow between subendocardium and subepicardium of a nonischemic region and one distal to a severe left clircumflex coronary artery stenosis was determined by use of tracer microspheres (15 ,) in intact dog hearts. DMP (1, 5 and 10 mg/kg I.V.) produced a small dose-related increase in endo/epi of the nonischemic region (1.15 0.04-1.24 ± 0.05), whereas a larger increase was observed in the ischemic region (0.61 0.08-1.09 ± 0.10). DMP also produced a significant increase in ischemic subendocardial blood flow (0.59 0.12-0.76 i 0.11 ml/min/g). Similarly, propranolol (0.5 and 1.0 mg/kg I.V.) produced a small increase in endo/epi of the nonischemic region (1.18 ± 0.08-1.30 ± 0.07) and a larger increase in the ischemic region (0.72 ± 0.17-1.18 ± 0.09). However, propranolol did not increase ischemic subendocardial blood flow. It is concluded that DMP may be an alternative to propranolol in certain types of acute myocardial ischemia when 3-adrenergic blockade is undesirable.
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THE N-DIMETHYL QUATERNARY salt of propranolol (DMP, UM-272, SC-27761) has been shown to possess antiarrhythmic and antifibrillatory properties in the intact canine heart.' 2 DMP has also been shown to reduce ST segment elevation during acute coronary artery occlusion.3 Furthermore, Lucchesi et al. 4 demonstrated that DMP reduced arrhythmias, ST segment alterations and myocardial infarct size in canine hearts subjected to a 60-minute coronary occlusion and subsequent 24-hour period of reperfusion.
Although DMP has no significant ,B-adrenergic blocking properties,' it produces a decrease in heart rate and myocardial contractility via direct effects on the sinoatrial node and ventricular myocardium. Thus, the mechanisms of the protective effect of DMP during acute myocardial ischemia has been attributed to its ability to reduce myocardial oxygen demands via its negative inotropic and chronotropic actions." Another possible explanation for the beneficial effect of DMP has been offered by Warltier et al. 6 These authors have shown that DMP infusion results in an increase in subendocardial blood flow in an isolated canine heart preparation perfused at a constant total coronary blood flow. If an increase in subendocardial flow occurred in an ischemic zone of the intact heart, this would be an additional mechanism by which DMP could reduce myocardial ischemia. Therefore, the purpose of the present investigation was to determine if DMP produces a favorable redistribution of blood flow to the subendocardium of a region made ischemic by a severe coronary artery stenosis. Propranolol was studied for purposes of comparison.
Methods General Preparation
Adult mongrel dogs of either sex, weighing 15 
where Qr is the rate of withdrawal of the reference blood sample, Cr is the activity (cpm) of the reference blood sample, and Cm is the activity (cpm/g) of the myocardial tissue sample. The three tissue areas of the base, middle and apex were pooled for the calculation of tissue blood flow in the subepicardium and subendocardium of the normal (LAD) and ischemic region (LC). Transmural blood flow was the weighted average obtained from the subepicardium and subendocardium of the normal and ischemic region of each heart.
Calculation of Indices
The tension time index (TTI) was calculated by determining the area under the aortic systolic blood CIRCULATION 664 The effect of propranolol on transmural blood flow gradients in anterior and posterior regions of the left ventricle are summarized in table 6. All doses of propranolol produced a small but significant increase in endo/epi in the anterior region. These changes were accompanied by significant decreases in subepicardial, subendocardial and transmural blood flow at the two higher doses (1, 5 mg/kg). Propranolol (0.5, 1 mg/kg) produced a large increase in endo/epi (0.72 ± 0.08 to 1.18 ± 0.09) in the ischemic posterior region of the left ventricle. These changes were primarily due to a selective decrease in subepicardial blood flow, whereas subendocardial flow was main- LV Anterior (control) Epicardium (ml/min/g) 150 minutes. In one group, the stenosis was stable during a 150-minute period, whereas in a second group, blood flow to the subendocardium progressively decreased and infarction occurred. In the stable group, subendocardial blood flow at 30 minutes after stenosis was 0.65 ml/min/g, whereas in the unstable group, subendocardial flow was 0.39 ml/min/g. In the present study, blood flow to the subendocardium in the three experimental groups averaged 0.60 ml/min/g (0.50-0.72 ml/min/g) at 30 minutes after stenosis. Thus, apparently sufficient subendocardial blood flow was present to insure a stable condition in the ischemic zone over the time period studied (120 minutes). The results of the present time control experiments support this view and agree with those of Guyton et al. 18 Therefore, this model of coronary artery stenosis offers a stable experimental preparation in which to study the effects of pharmacological agents on ischemic myocardial blood flow distribution.
The results of the present study have shown that both DMP and propranolol favorably alter the balance between myocardial oxygen supply and de- 
LV Anterior (control) Epicardium (ml/min/g) ' have stressed the importance of heart rate. The results of the present study do not conclusively answer this question, but do indicate that DMP has both negative inotropic and chronotropic effects and improves the myocardial oxygen supply-demand relationship by increasing DPTI/TTI. In addition, the increase in subendocardial blood flow observed after DMP during low flow perfusion adds an additional mechanism as to how DMP may reduce myocardial ischemia. Furthermore, the question as to whether the increase in subendocardial blood flow produced by DMP results in an improvement in regional contractile function needs to be answered in future experiments. Beta-adrenergic blockade produced by propranolol has been shown to be effective in reducing the frequency of certain types of cardiac arrhythmias.2 8 5 In addition, propranolol is an effective antianginal agent and has been shown to reduce myocardial infarct size in experimental animals.4 12, 13 However, many of the undesirable properties of f3-adrenergic blockade have prevented its use, particularly in patients with asthma, congestive heart failure, or during myocardial infarction accompanied by pump failure.' The results of this study and those of others2-6 suggest that DMP may be a viable alternative as an antiarrhythmic and antifibrillatory agent in certain types of ischemic heart disease where ,B-adrenergic blockade is undesirable. Furthermore, the results obtained with the high dose of propranolol indicate that caution must be used when administering this agent to a marginally failing heart.
